UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 38

Sortiert nach

Adalimumab produces clinical remission and reduces extraintestinal manifestations in Crohn's disease: Results from CARE

Inflammatory bowel diseases, 2012-01, Vol.18 (1), p.1-9

2012

Volltextzugriff (PDF)

Demographic and clinical parameters influencing the short-term outcome of anti-tumor necrosis factor (infliximab) treatment in Crohn's disease

The American journal of gastroenterology, 2002-09, Vol.97 (9), p.2357-2363

2002

Volltextzugriff (PDF)

Early Mucosal Healing Predicts Favorable Outcomes in Patients With Moderate to Severe Ulcerative Colitis Treated With Golimumab: Data From the Real-life BE-SMART Cohort

Inflammatory bowel diseases, 2019-01, Vol.25 (1), p.156-162

2019

Volltextzugriff (PDF)

Serum adalimumab concentration and clinical remission in patients with Crohn's disease

Inflammatory bowel diseases, 2013-05, Vol.19 (6), p.1112-1122

2013

Volltextzugriff (PDF)

Incidence and Predictors of Success of Adalimumab Dose Escalation and De-escalation in Ulcerative Colitis: a Real-World Belgian Cohort Study

Inflammatory bowel diseases, 2018-04, Vol.24 (5), p.1099-1105

2018

Volltextzugriff (PDF)

Consecutive fecal calprotectin measurements to predict relapse in patients with ulcerative colitis receiving infliximab maintenance therapy

Inflammatory bowel diseases, 2013-09, Vol.19 (10), p.2111-2117

2013

Volltextzugriff (PDF)

Dyspeptic symptoms in the general population: a factor and cluster analysis of symptom groupings

Neurogastroenterology and motility, 2009-04, Vol.21 (4), p.378-388

2009

Volltextzugriff (PDF)

Assessment of endoscopic activity index and biological inflammatory markers in clinically active Crohn's disease with normal C‐reactive protein serum level

Inflammatory bowel diseases, 2007-09, Vol.13 (9), p.1100-1105

2007

Volltextzugriff (PDF)

Genome-Wide Copy Number Variation Scan Identifies Complement Component C4 as Novel Susceptibility Gene for Crohn's Disease

Inflammatory bowel diseases, 2016-03, Vol.22 (3), p.505-515

2016

Volltextzugriff (PDF)

A multicentre prospective cohort study assessing the effectiveness of budesonide MMX® (Cortiment®MMX®) for active, mild-to-moderate ulcerative colitis

United European gastroenterology journal, 2019-11, Vol.7 (9), p.1171-1182

2019

Volltextzugriff (PDF)

Costs of Crohn's Disease According to Severity States in France: A Prospective Observational Study and Statistical Modeling over 10 Years

Inflammatory bowel diseases, 2016-12, Vol.22 (12), p.2924-2932

2016

Volltextzugriff (PDF)

Association between polymorphism in IgG Fc receptor IIIa coding gene and biological response to infliximab in Crohn's disease

Alimentary pharmacology & therapeutics, 2004-03, Vol.19 (5), p.511-519

2004

Volltextzugriff (PDF)

Tumour necrosis factor (TNF) gene polymorphism influences TNF‐α production in lipopolysaccharide (LPS)‐stimulated whole blood cell culture in healthy humans

Clinical and experimental immunology, 1998-09, Vol.113 (3), p.401-406

1998

Volltextzugriff (PDF)

Clinical and genetic factors associated with sacroiliitis in Crohn's disease

Journal of gastroenterology and hepatology, 2008-01, Vol.23 (1), p.132-137

2008

Volltextzugriff (PDF)

Gastric exocrine and endocrine cell morphology under prolonged acid inhibition therapy: results of a 5-year follow-up in the LOTUS trial

Alimentary pharmacology & therapeutics, 2012-11, Vol.36 (10), p.959-971

2012

Volltextzugriff (PDF)

Long-Term Outcome of Microscopic Esophagitis in Chronic GERD Patients Treated With Esomeprazole or Laparoscopic Antireflux Surgery in the LOTUS Trial

The American journal of gastroenterology, 2010-05, Vol.105 (5), p.1015-1023

2010

Volltextzugriff (PDF)

Serological markers for prediction of response to anti-tumor necrosis factor treatment in Crohn's disease

The American journal of gastroenterology, 2002-06, Vol.97 (6), p.1458-1462

2002

Volltextzugriff (PDF)

Rapid improvement of bone metabolism after infliximab treatment in Crohn's disease

Alimentary pharmacology & therapeutics, 2004-09, Vol.20 (6), p.607-614

2004

Volltextzugriff (PDF)

Increased production of matrix metalloproteinase‐3 and tissue inhibitor of metalloproteinase‐1 by inflamed mucosa in inflammatory bowel disease

Clinical and experimental immunology, 2000-05, Vol.120 (2), p.241-246

2000

Volltextzugriff (PDF)

Lack of association between adult asthma and the tumour necrosis factor alpha-308 polymorphism gene

The European respiratory journal, 2000-10, Vol.16 (4), p.604-608

2000

Volltextzugriff (PDF)

Cytokine production from peripheral whole blood in atopic and nonatopic asthmatics: relationship with blood and sputum eosinophilia and serum IgE levels

Allergy (Copenhagen), 2000-12, Vol.55 (12), p.1134-1141

2000

Volltextzugriff (PDF)

Multidrug resistance gene‐1 polymorphisms and resistance to cyclosporine a in patients with steroid resistant ulcerative colitis

Inflammatory bowel diseases, 2007-01, Vol.13 (1), p.19-23

2007

Volltextzugriff (PDF)

Cytokine production from sputum cells after allergenic challenge in IgE‐mediated asthma

Allergy (Copenhagen), 2002-12, Vol.57 (12), p.1145-1150

2002

Volltextzugriff (PDF)

Tumour necrosis factor (TNF) gene polymorphism in Crohn's disease (CD): influence on disease behaviour?

Clinical and experimental immunology, 2000-01, Vol.119 (1), p.64-68

2000

Volltextzugriff (PDF)

Multicenter randomized-controlled clinical trial of probiotics (Lactobacillus johnsonii, LA1) on early endoscopic recurrence of Crohn's disease after lleo-caecal resection

Inflammatory bowel diseases, 2007-02, Vol.13 (2), p.135-142

2007

Volltextzugriff (PDF)

1 – 25 von 38

Suche als RSS-Feed

Aktive Filter

KollektionWiley Online Library Journals Frontfile Complete

ThemaMiddle Aged

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(37)
Mit Volltextzugriff
(33)

Publikationsform

Artikel
(38)

Sprache

Englisch
(38)
Japanisch
(11)

Erscheinungsjahr

n.n

Thema

Humans
(38)
Adult
(37)
Female
(35)
Male
(35)
Life Sciences & Biomedicine
(33)
Science & Technology
(33)
Gastroenterology & Hepatology
(23)
Human Health Sciences
(22)
Sciences De La Santé Humaine
(22)
Biological And Medical Sciences
(20)
Aged
(19)
Gastroentérologie & Hépatologie
(19)
Medical Sciences
(19)
Adolescent
(14)
Treatment Outcome
(13)
Gastroenterology. Liver. Pancreas. Abdomen
(10)
Young Adult
(9)
Crohn's Disease
(8)
Follow-Up Studies
(8)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Adalimumab produces clinical remission and reduces extraintestinal manifestations in Crohn's disease: Results from CARE

Demographic and clinical parameters influencing the short-term outcome of anti-tumor necrosis factor (infliximab) treatment in Crohn's disease

Early Mucosal Healing Predicts Favorable Outcomes in Patients With Moderate to Severe Ulcerative Colitis Treated With Golimumab: Data From the Real-life BE-SMART Cohort

Serum adalimumab concentration and clinical remission in patients with Crohn's disease

Incidence and Predictors of Success of Adalimumab Dose Escalation and De-escalation in Ulcerative Colitis: a Real-World Belgian Cohort Study

Consecutive fecal calprotectin measurements to predict relapse in patients with ulcerative colitis receiving infliximab maintenance therapy

Dyspeptic symptoms in the general population: a factor and cluster analysis of symptom groupings

Assessment of endoscopic activity index and biological inflammatory markers in clinically active Crohn's disease with normal C‐reactive protein serum level

Genome-Wide Copy Number Variation Scan Identifies Complement Component C4 as Novel Susceptibility Gene for Crohn's Disease

A multicentre prospective cohort study assessing the effectiveness of budesonide MMX® (Cortiment®MMX®) for active, mild-to-moderate ulcerative colitis

Costs of Crohn's Disease According to Severity States in France: A Prospective Observational Study and Statistical Modeling over 10 Years

Association between polymorphism in IgG Fc receptor IIIa coding gene and biological response to infliximab in Crohn's disease

Tumour necrosis factor (TNF) gene polymorphism influences TNF‐α production in lipopolysaccharide (LPS)‐stimulated whole blood cell culture in healthy humans

Clinical and genetic factors associated with sacroiliitis in Crohn's disease

Gastric exocrine and endocrine cell morphology under prolonged acid inhibition therapy: results of a 5-year follow-up in the LOTUS trial

Long-Term Outcome of Microscopic Esophagitis in Chronic GERD Patients Treated With Esomeprazole or Laparoscopic Antireflux Surgery in the LOTUS Trial

Serological markers for prediction of response to anti-tumor necrosis factor treatment in Crohn's disease

Rapid improvement of bone metabolism after infliximab treatment in Crohn's disease

Increased production of matrix metalloproteinase‐3 and tissue inhibitor of metalloproteinase‐1 by inflamed mucosa in inflammatory bowel disease

Lack of association between adult asthma and the tumour necrosis factor alpha-308 polymorphism gene

Cytokine production from peripheral whole blood in atopic and nonatopic asthmatics: relationship with blood and sputum eosinophilia and serum IgE levels

Multidrug resistance gene‐1 polymorphisms and resistance to cyclosporine a in patients with steroid resistant ulcerative colitis

Cytokine production from sputum cells after allergenic challenge in IgE‐mediated asthma

Tumour necrosis factor (TNF) gene polymorphism in Crohn's disease (CD): influence on disease behaviour?

Multicenter randomized-controlled clinical trial of probiotics (Lactobacillus johnsonii, LA1) on early endoscopic recurrence of Crohn's disease after lleo-caecal resection

Aktive Filter

Suchergebnisse filtern